Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQR2NObVIxdlYxZmFlOHJpc3RxZC1wVlNKYW10bGROcmdNVjV4blZRTFZCNHhMeTVfeGxpd19Iemp4aUVNRG9Md0laNkFFZUFRbzJja0ZjYXhsYTRJRUF1M1ozclN1UDg3TnNFSWstQ0ZJMGFISUdMTFhRZmtGZmVnRWNhVWFFY1ROVEJHZWJ2YmVxc0RQV0txaGdRLTVqWTEyN0ZHQUljTQ?oc=5" target="_blank">Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal Reuters
October 6, 2026 at 04:30 PMNvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PMDental firm vVardis reveals revenue surge in US IPO filing - Reuters
Dental firm vVardis reveals revenue surge in US IPO filing Reuters
October 9, 2026 at 07:31 PMMcKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports - Reuters
McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports Reuters
October 5, 2026 at 09:09 PMBecton Dickinson pledges $19 billion US investment in deal with government - Reuters
Becton Dickinson pledges $19 billion US investment in deal with government Reuters
October 6, 2026 at 03:06 PMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PM